Key Findings:  The neuroprotective effect of nerolidol is mediated through its anti-oxidant and anti-inflammatory activities, which strongly supports its therapeutic potential for the treatment of Parkinson's Disease.
Type of Study:  Animal Study
Study Result:  Positive
Study Location(s):  United Arab Emirates
Year of Pub:  2016
Cannabinoids Studied:  Cannabinoid (unspecified)
Phytocannabinoid Source:  Not Applicable
Terpenes Studied:  Nerolidol
Ligands Studied:  Dopamine
DOSING DETAILS   
Study Dosing Objective:  Effective Dose
Established Protocol:  Effective dose
Route of Administration:  Injection
Dosing Regimen:  Nerolidol 50 mg/kg of body weight, once a day
Treatment Duration:  4 weeks
Clinical Relevance:  Nerolidol shows promising neuroprotective effects through its anti-oxidant and anti-inflammatory activities, which may offer therapeutic potential for treating Parkinson's disease.